3Teratani,G., Awano, S., Soh,I. et al. Oral health in patients on haemodialysis for diabetic nephropathy and chronic glomerulonephritis.Clinical oral investigations, 2013,17(2):483-489.
4Kaliev R, Murkamilov I T, Fomin V V, et al. Effect of erythropoietin and its combination with hypoxic altitude chamber training on the clinical and functional manifestations of chronic glomerulonephritis [J]. Ter Arkh, 2014, 86(10): 40-46.
5原发性肾小球疾病分型与治疗诊断标准专题座谈会纪要.中华内科杂志,1993,32:129.
6Souqiyyeh M Z, Shaheen F A, Alsuwaida A, et al. Rituximab as a rescue therapy in patients with glomerulonephritis [J]. Saudi J Kidney Dis Transpl, 2015 26(1): 47-55.
7Sedighi O, Abediankenari S, Omranifar B. Association between plasma Beta-2 microglobulin level and cardiac performance in patients with chronic kidney disease [J]. Nephrourol Mon, 2014, 7(1): e23563.
8Yoon Y E, Choi K H, Lee K S, et al. Impact of metabolic syndrome on postdonation renal function in living kidney donors [J]. Transplant Proc, 2015, 47(2): 290-294.
9Nishikawa K, Takahashi K, Okutani T, et al. Risk of chronic kidney disease in non-obese individuals with clustering of metabolic factors: a longitudinal study [J]. Intern Med, 2015, 54(4): 375-382.
